Home > National Drug Code (NDC) > Broncotron PED

Broncotron PED - 11026-2780-4 - (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl)

Alphabetical Index


Drug Information of Broncotron PED

Product NDC: 11026-2780
Proprietary Name: Broncotron PED
Non Proprietary Name: Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Active Ingredient(s): 15; 350; 10    mg/5mL; mg/5mL; mg/5mL & nbsp;   Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Broncotron PED

Product NDC: 11026-2780
Labeler Name: Seyer Pharmatec, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20121215

Package Information of Broncotron PED

Package NDC: 11026-2780-4
Package Description: 1 BOTTLE in 1 CARTON (11026-2780-4) > 118 mL in 1 BOTTLE

NDC Information of Broncotron PED

NDC Code 11026-2780-4
Proprietary Name Broncotron PED
Package Description 1 BOTTLE in 1 CARTON (11026-2780-4) > 118 mL in 1 BOTTLE
Product NDC 11026-2780
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20121215
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Seyer Pharmatec, Inc.
Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 15; 350; 10
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes

Complete Information of Broncotron PED


General Information